Edenred plunges after its end-September update. Edenred fell 5.1% to €27.7 after the services group reported total revenue of €2.198bn at the end of September, up 1% on a reported basis and 0.6% on a like-for-like basis compared with the first nine months of 2025. Published on 10/21/2026 at 04:39 am EDT MarketScreener.com - Translated by Marketscreener - See original The payment solutions provider's operating revenue was virtually stable on a reported basis, up 0.6% to €2.027bn, and increased 1.1% on a like-for-like basis in the first nine months of this year. In the third quarter alone, its operating revenue came to €667m, down 1.2% on a like-for-like basis, due to the effects of regulatory changes concerning meal vouchers in Italy and Brazil. Excluding those effects, it would have posted underlying growth of 6.6%. Based on what it described as solid third-quarter revenue growth, Edenred confirmed its 2026 targets, a year of adjustment to its business base amid regulatory reforms in Italy and Brazil concerning its meals and food business. Edenred confirmed its forecast for a 7% to 10% decline in EBITDA on a like-for-like basis in 2026. "However, the group lowered its reported EBITDA range by €10m, now expecting it to come in between €1.22bn and €1.26bn, to account for the disposal of Edenred North America," Jefferies noted. "This forecast is broadly consistent with consensus, which anticipates an 8% organic decline, but remains below our expectation of a 5% decline," the U.S. investment bank said, maintaining its "hold" rating and €27.5 price target. (C) MarketScreener.com - 2026

Why is Edenred stock sliding today? Published Oct 21, 2026, 03:27 AM (C) Reuters. Investing.com - Edenred stock is falling 3.0% to trade at €28.34 during today's session after the French digital payments and employee benefits group published its third-quarter 2026 revenue results before the market open, confirming that regulatory headwinds in two of its most important markets are still suppressing reported growth. Operating revenue for the quarter reached €667 million, flat on a reported basis but down 1.2% on a like-for-like comparison with the same period a year earlier, while total revenue of €725 million came in ahead of the analyst consensus of approximately €709 million. The company reiterated its full-year 2026 guidance, which calls for a like-for-like EBITDA decline in the range of roughly 7% to 10%, framing 2026 as a "rebasing year" shaped by ongoing regulatory changes affecting meal vouchers in Italy and Brazil - headwinds that have collectively eroded tens of millions of euros in revenue versus the underlying business trajectory. Stripping out the regulatory impact, Edenred's intrinsic growth for the first nine months of 2026 ran at approximately 7.6% in operating revenue, driven largely by double-digit comparable growth in the Mobility segment. CFO Virginie Duperat-Vergne described Mobility as still an early-stage activity with a steeper growth curve, particularly as electric vehicle adoption expands across new markets. On the analyst side, UBS raised its price target to €28.50 from €19.00 on October 16 while keeping a neutral rating - a target that sits below the pre-results trading level - citing regulatory uncertainty in Brazil and potential merchant commission pressure as key risks. -39.75 (-0.52%) Closed · 23/10 · USD Morgan Stanley maintained a more constructive Overweight stance with a €35 target, but the market's reaction today suggests investors are anchoring on the confirmed earnings decline rather than the longer-term recovery thesis. From a broader market perspective, U.S. equity benchmarks were modestly positive on the day, with the S&P 500 adding 0.2% and the Nasdaq gaining 0.6%, indicating that the pressure on Edenred is company-specific rather than a reflection of a risk-off macro environment. The stock's direct peer Pluxee, which faces similar regulatory exposure in the French and Brazilian meal voucher markets, has also been under pressure in recent weeks, suggesting the sector-level regulatory overhang remains a shared concern for the employee benefits industry. Taken together, today's move reflects a market that had priced in some improvement ahead of the Q3 release - the stock had rallied meaningfully from its 52-week low of €15.23 - but found the combination of a like-for-like revenue decline, a beat driven largely by Mobility, and an unchanged EBITDA decline guidance insufficient to sustain the recent re-rating. With the stock now at €28.34, it sits well below its 52-week high of €30.85, as investors reassess the pace at which Edenred can return to earnings growth once the regulatory reset in Italy and Brazil is fully absorbed. Should you invest $2,000 in EDEN right now? ProPicks AI evaluates EDEN alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias - it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if EDEN is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?

Edenred shares have risen about 60% so far this year, raising the question of whether earnings justify the price. The stock trades on about 13.9 times earnings. That is slightly above the diversified financial industry average of roughly 12.8x, and below the peer group average of about 15.0x. A Simply Wall St "Fair Ratio" benchmark, which weighs profitability, size and sector risks, points to a higher multiple, suggesting the market is applying a discount. Investors are split. Bulls cite Beyond Food and Beyond Fuel offers, which account for more than 40% of revenue. Bears point to a 6.6% rise in first-half 2026 operating expenses and a drop in operating EBITDA margin to 37%, and call the stock 45% overvalued.